Department of Abdominal Surgery, Ziekenhuis Oost-Limburg, Schiepse Bos 6, 3600 Genk, Belgium.
Obes Surg. 2012 Jan;22(1):152-7. doi: 10.1007/s11695-011-0427-9.
Since March 2003, we have used the Cousin Bioring in our laparoscopic gastroplasty procedures for morbid obesity. The Bioring belongs to the new generation of adjustable gastric bands. The aim of this study is to review our experience with this particular type of band.
Between March 2003 and March 2010, 316 patients had a laparoscopic implantation of the Cousin Bioring in our department. As many as 169 patients had the operation at least 5 years ago, of which 161 had a complete follow-up. Short- and long-term results were prospectively collected and analysed.
There were no intra-operative and only two mild early post-operative complications. Mortality was zero. The mean percent of excess weight loss (%EWL) was 56% at 5 years, 55% at 6 years and 56% at 7 years. Of the 169 patients, four had a band removal for intolerance and/or insufficient weight loss and 11 (6.5%) developed late complications requiring surgery. We managed to solve all complications by minimally invasive procedures without loss of the device. Fifteen of the 169 patients suffered preoperatively from diabetes mellitus type 2. Ten of these had a remission after 5 years. The quality-of-life was assessed 3 years post-operatively for 164 patients and showed an improvement in 83.5% of them.
Laparoscopic implantation of the Cousin Bioring is a straightforward and safe operation. Complications occur, but they are rather benign and easy to remediate. The mean weight loss is considered successful (%EWL > 50) and persists 5 to 7 years after the operation.
自 2003 年 3 月以来,我们在腹腔镜胃减容术中使用 Cousin Bioring 胃带。Bioring 属于新一代可调节胃带。本研究旨在回顾我们使用这种特殊类型胃带的经验。
2003 年 3 月至 2010 年 3 月期间,我科共对 316 例病态肥胖患者进行了腹腔镜植入 Cousin Bioring。其中 169 例患者至少在 5 年前接受了手术,其中 161 例患者有完整的随访资料。我们前瞻性地收集和分析了短期和长期结果。
术中无并发症,仅有 2 例轻度早期术后并发症。无死亡病例。5 年时的平均超重百分比(%EWL)为 56%,6 年时为 55%,7 年时为 56%。169 例患者中,4 例因不耐受和/或减重不足而取出胃带,11 例(6.5%)发生需要手术治疗的迟发性并发症。我们通过微创方法成功解决了所有并发症,且未丢失装置。169 例患者中有 15 例术前患有 2 型糖尿病。其中 10 例在 5 年后缓解。对 164 例患者术后 3 年进行生活质量评估,83.5%的患者生活质量得到改善。
腹腔镜植入 Cousin Bioring 是一种简单、安全的手术。并发症虽然存在,但较为良性,易于处理。平均减重效果被认为是成功的(%EWL > 50),并且在手术后 5 至 7 年内持续存在。